
USD
+$0.00
(+0.00%
)At Close (As of Oct 23, 2025)
$8.04M
Market Cap
-
P/E Ratio
-3.31
EPS
$2.65
52 Week High
$0.72
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $3.8M |
| Total Revenue | $120M |
| Cost Of Revenue | $116M |
| Costof Goods And Services Sold | $116M |
| Operating Income | -$1M |
| Selling General And Administrative | $3.3M |
| Research And Development | - |
| Operating Expenses | $4.9M |
| Investment Income Net | - |
| Net Interest Income | $93K |
| Interest Income | $93K |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $6M |
| Income Before Tax | -$951K |
| Income Tax Expense | $504K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$1.5M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$1M |
| Ebitda | $5M |
| Net Income | $10M |
| Field | Value (USD) |
|---|---|
| Total Assets | $64M |
| Total Current Assets | $60M |
| Cash And Cash Equivalents At Carrying Value | $13M |
| Cash And Short Term Investments | $13M |
| Inventory | $9.8M |
| Current Net Receivables | $30M |
| Total Non Current Assets | $4.8M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $3.3M |
| Intangible Assets Excluding Goodwill | $3.3M |
| Goodwill | $1.5M |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $6.9M |
| Other Non Current Assets | - |
| Total Liabilities | $35M |
| Total Current Liabilities | $34M |
| Current Accounts Payable | $20M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $10M |
| Total Non Current Liabilities | $492K |
| Capital Lease Obligations | - |
| Long Term Debt | - |
| Current Long Term Debt | $10M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $10M |
| Other Current Liabilities | $2.5M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $30M |
| Treasury Stock | - |
| Retained Earnings | -$63M |
| Common Stock | $1.4M |
| Common Stock Shares Outstanding | $5.5M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $1.2M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $6M |
| Capital Expenditures | $615K |
| Change In Receivables | - |
| Change In Inventory | $406K |
| Profit Loss | - |
| Cashflow From Investment | -$18M |
| Cashflow From Financing | $1.5M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $10M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $3.8M |
| Total Revenue | $120M |
| Cost Of Revenue | $116M |
| Costof Goods And Services Sold | $116M |
| Operating Income | -$1M |
| Selling General And Administrative | $3.3M |
| Research And Development | - |
| Operating Expenses | $4.9M |
| Investment Income Net | - |
| Net Interest Income | $93K |
| Interest Income | $93K |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $6M |
| Income Before Tax | -$951K |
| Income Tax Expense | $504K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$1.5M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$1M |
| Ebitda | $5M |
| Net Income | $10M |
Sector: HEALTHCARE
Industry: PHARMACEUTICAL RETAILERS
Ridgetech, Inc. (RDGT) is a leading distributor in the pharmaceutical and healthcare sector, primarily operating within the People's Republic of China. Based in Hangzhou, the company capitalizes on its expansive network of drugstores to offer a wide array of quality healthcare products, thereby addressing the increasing demand for accessible medical solutions in the region. With a strong grasp of the local market and regulatory frameworks, Ridgetech has established itself as a reliable partner in the dynamic and rapidly evolving Chinese healthcare landscape, committed to enhancing consumer access to essential pharmaceutical resources.